Stock listing

NASDAQ:PYPD PolyPid Ltd. Stock

Home listing (NASDAQ) of PolyPid Ltd.

Follow PolyPid Ltd. into a list and get an email when it puts out news.

Share price · NASDAQ:PYPD

$6.12 USD -0.44 (-6.7%)

Close on Nov 20, 2026

Past year +68.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$6.09 – $6.76 USDNov 20, 2026
Volume
448,947 sharesNov 20, 2026
Market cap
$124.3M USDAt the close on Nov 20, 2026 · price × 20.31M shares outstanding
52-week range
$3.50 – $7.14 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$805,215 USDMedian day 113,400 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
PolyPid Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:PYPD · Home$6.12 USD-0.44 (-6.7%)448,947$6.55$6.76$6.09$6.56Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:PYPD · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$6.12-0.44-6.7%$6.55$6.76$6.09448,947
$6.56+0.02+0.3%$6.60$6.80$6.46303,794
$6.54+0.39+6.3%$6.21$6.57$6.12761,469
$6.15-0.11-1.8%$6.23$6.25$6.03211,749
$6.26-0.14-2.2%$6.58$6.58$6.03193,125
$6.40-0.20-3.0%$6.968$6.968$6.33188,305
$6.60+0.29+4.6%$6.50$7.14$6.18424,498
$6.31+0.07+1.1%$6.24$6.35$5.90151,914
$6.24+0.10+1.6%$6.17$6.48$6.055263,284
$6.14+0.47+8.3%$5.71$6.14$5.52183,944
$5.67-0.15-2.6%$5.82$5.93$5.36241,864
$5.82+0.36+6.6%$5.56$5.89$5.56170,245
$5.46+0.04+0.7%$5.74$5.74$5.32100,437
$5.42+0.03+0.6%$5.548$5.69$5.27205,692
$5.39-0.20-3.6%$5.54$5.59$5.39100,724
$5.59-0.19-3.3%$5.84$5.84$5.5593,269
$5.78+0.01+0.2%$5.77$5.80$5.54134,846
$5.77+0.48+9.1%$5.34$5.79$5.34228,926
$5.29+0.04+0.8%$5.25$5.365$5.1793,977
$5.25+0.12+2.3%$5.14$5.25$5.11103,800
$5.13+0.06+1.2%$5.02$5.19$4.92155,300
$5.07-0.08-1.6%$5.19$5.21$5.00137,100
$5.15+0.27+5.5%$4.88$5.17$4.77109,500
$4.88+0.16+3.4%$5.00$5.091$4.77110,700
$4.72-0.18-3.7%$4.82$4.90$4.72150,500
$4.90+0.07+1.4%$4.70$4.97$4.61120,600
$4.83-0.05-1.0%$4.89$4.95$4.75133,100
$4.88-0.14-2.8%$5.04$5.08$4.8093,400
$5.02-0.05-1.0%$5.07$5.10$5.0077,600
$5.07+0.17+3.5%$4.91$5.16$4.9060,000
$4.90-0.05-1.0%$4.92$4.99$4.7588,900
$4.95-0.18-3.5%$5.11$5.19$4.90113,400
$5.13-0.07-1.3%$5.22$5.24$5.0586,600
$5.20+0.01+0.2%$5.28$5.33$5.03102,000
$5.19-0.18-3.4%$5.49$5.55$5.06167,700
$5.37+0.10+1.9%$5.30$5.47$5.28118,800
$5.27-0.02-0.4%$5.27$5.355$5.1647,400
$5.29-0.02-0.4%$5.40$5.40$5.2366,000
$5.31+0.09+1.7%$5.22$5.43$5.18675,800
$5.22-0.14-2.6%$5.33$5.45$5.2244,800
$5.36+0.09+1.7%$5.27$5.365$5.1960,200
$5.27-0.18-3.3%$5.43$5.43$5.1069,100
$5.45+0.28+5.4%$5.19$5.464$5.19127,000
$5.17-0.04-0.8%$5.22$5.345$5.1240,600
$5.21+0.18+3.6%$5.06$5.30$5.0666,400
$5.03-0.18-3.5%$5.25$5.34$5.03105,000
$5.21+0.05+1.0%$5.15$5.22$5.0076,500
$5.16-0.17-3.2%$5.32$5.33$5.0381,700
$5.33+0.18+3.5%$5.18$5.35$5.14180,700
$5.15-0.01-0.2%$5.20$5.24$5.0499,300
$5.16-0.04-0.8%$5.20$5.382$5.1369,600
$5.20-0.13-2.4%$5.22$5.39$5.16141,600
$5.33-0.06-1.1%$5.39$5.565$5.23587,300
$5.39+0.12+2.3%$5.30$5.44$5.2173,100
$5.27-0.03-0.6%$5.36$5.36$5.2065,500
$5.30-0.03-0.6%$5.32$5.35$5.16143,800
$5.33+0.19+3.7%$5.17$5.55$5.14242,100
$5.14+0.07+1.4%$5.08$5.15$5.0055,600
$5.07-0.05-1.0%$5.13$5.145$4.98563,500
$5.12+0.01+0.2%$5.18$5.24$5.0178,100
$5.11+0.01+0.2%$5.07$5.23$4.96149,300
$5.10+0.115+2.3%$5.04$5.19$5.015139,606
$4.985-0.115-2.3%$5.12$5.18$4.97124,422
$5.10+0.02+0.4%$5.10$5.205$4.99169,100
$5.08+0.07+1.4%$5.04$5.12$4.96129,400

Splits

1 split · NASDAQ:PYPD · every price before a split is adjusted for it

DayRatioWhat
1-for-30Consolidation
Ticker
NASDAQ:PYPD
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All PolyPid Ltd. news

PolyPid Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
27 in the last 12 months · 145 in all · newest Nov 11, 2026 · oldest 2020
Calls
23 calls with a replay · 23 with a transcript · latest Nov 11, 2026
Decks
7 decks · latest August 2026

Where PolyPid Ltd. is listed

ListingExchangeCountryCurrency
NASDAQ:PYPD · Home listing · This pageNASDAQUnited StatesUSD
BOATS:PYPDBOATSUnited StatesUSD
Frankfurt:2PVFrankfurtGermanyEUR

Cash and shares

Jun 30, 2026 · PolyPid — Investor Presentation (August 2026)

Shares outstanding
20.3 million

The slide these figures come from

Valuation

Price/book 23.1× against a median of 3.2×: the highest of 11 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$119.3M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
23.1×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.3×
Beta vs S&P 500
0.93

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
PolyPid Ltd. · NASDAQ:PYPDUS$124.3MUS$119.3Mn/an/an/a23.1×n/a0.3×0.93
Yoda Pharmaceuticals Inc. · TPEX:7829US$127.1MUS$94.37Mn/an/an/a3.9×n/a0.0×n/a
IntoCell, Inc. · KRX:287840US$126.6MUS$108.8Mn/a45.9×n/a8.7×−295.9%0.0×n/a
UnicoCell Biomed Co., Ltd. · TWSE:6794US$126.3MUS$106.5Mn/a117×n/a5.1×−381.5%0.1×n/a
MacroGenics, Inc. · NASDAQ:MGNXUS$125.3M−US$127.6Mn/a−0.9×n/a5.0×−34.6%1.4×0.83
Compass Therapeutics, Inc. · NASDAQ:CMPXUS$123.9M−US$29.89Mn/an/an/a0.9×n/a0.1×1.22
Humacyte, Inc. · NASDAQ:HUMAUS$123.7MUS$96.01Mn/a40.1×n/a6.8×n/a2.0×2.56
Biomm SA · BMFBOVESPA:BIOM3US$122.6MUS$136.5M18.4×2.1×12.3×2.2×10.3%0.3×n/a
Invivyd, Inc. · NASDAQ:IVVDUS$122.0MUS$3.86Mn/a0.1×n/a0.8×−214.8%0.1×2.06
Satellos Bioscience Inc · TSX:MSCLUS$121.9MUS$69.23Mn/an/an/a2.5×n/a0.0×0.49
Alar Pharmaceuticals Inc · TPEX:6785US$121.0MUS$51.66Mn/a568×n/a1.7×n/a0.0×n/a
Median of the othersUS$123.8MUS$81.80M18.4×40.1×12.3×3.2×−214.8%0.1×1.22

Forecasts

4 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 13, 2026. Not 6ix's view and not investment advice.

Price target
11.50 USD · Analysts' mean
EPS, year to Dec 2026
0.10 · 3 analysts
Revenue, year to Dec 2026
21.05M · 5 analysts

Team and board

Officers

OfficerRole
Dikla Czaczkes AkselbradChief Executive Officer
Ori WarshavskyPolyPid Investor Relations and Media Contacts

Board

DirectorRole
Brooke StoryChairman of the Board
Jacob HarelDirector

Events

Calls

CallWhenStatus
PolyPid (NASDAQ:PYPD) Q3 2026 Earnings CallWed, Nov 11, 2026 · 8:30 AM ETReplay
PolyPid (NASDAQ:PYPD) Q2 2026 Earnings CallWed, Aug 12, 2026 · 8:30 AM ETReplay
PolyPid (NASDAQ:PYPD) Q1 2026 Earnings CallWed, May 13, 2026 · 8:30 AM ETReplay
PolyPid (NASDAQ:PYPD) Q4 2025 Earnings CallWed, Feb 11, 2026 · 8:30 AM ETReplay
PolyPid (NASDAQ:PYPD) Q3 2025 Earnings CallWed, Nov 12, 2025 · 8:30 AM ETReplay
PolyPid (NASDAQ:PYPD) Q2 2025 Earnings CallWed, Aug 13, 2025 · 8:30 AM ETReplay
PolyPid (NASDAQ:PYPD) Q1 2025 Earnings CallWed, May 14, 2025 · 8:30 AM ETReplay
PolyPid (NASDAQ:PYPD) Q4 2024 Earnings CallWed, Feb 12, 2025 · 8:30 AM ETReplay
PolyPid (NASDAQ:PYPD) Q2 2024 Earnings CallWed, Aug 14, 2024 · 8:30 AM ETReplay
PolyPid (NASDAQ:PYPD) Q1 2024 Earnings CallWed, May 08, 2024 · 8:30 AM ETReplay
All 23 calls
CallWhenStatus
PolyPid (NASDAQ:PYPD) Q4 2023 Earnings CallWed, Feb 14, 2024 · 8:30 AM ETReplay
PolyPid (NASDAQ:PYPD) Q3 2023 Earnings CallWed, Nov 08, 2023 · 8:30 AM ETReplay
PolyPid (NASDAQ:PYPD) Q2 2023 Earnings CallWed, Aug 09, 2023 · 8:30 AM ETReplay
PolyPid (NASDAQ:PYPD) Q1 2023 Earnings CallWed, May 10, 2023 · 8:30 AM ETReplay
PolyPid (NASDAQ:PYPD) Q4 2022 Earnings CallWed, Feb 08, 2023 · 8:30 AM ETReplay
PolyPid (NASDAQ:PYPD) Q3 2022 Earnings CallWed, Nov 09, 2022 · 8:30 AM ETReplay
PolyPid (NASDAQ:PYPD) Q2 2022 Earnings CallWed, Aug 10, 2022 · 8:30 AM ETReplay
PolyPid (NASDAQ:PYPD) Q1 2022 Earnings CallWed, May 11, 2022 · 8:30 AM ETReplay
PolyPid (NASDAQ:PYPD) Q4 2021 Earnings CallWed, Feb 09, 2022 · 8:30 AM ETReplay
PolyPid (NASDAQ:PYPD) Q3 2021 Earnings CallWed, Nov 10, 2021 · 8:30 AM ETReplay
PolyPid (NASDAQ:PYPD) Q2 2021 Earnings CallWed, Aug 11, 2021 · 8:30 AM ETReplay
PolyPid (NASDAQ:PYPD) Q1 2021 Earnings CallWed, May 12, 2021 · 8:30 AM ETReplay
PolyPid (NASDAQ:PYPD) Q4 2020 Earnings CallWed, Feb 10, 2021 · 8:30 AM ETReplay

Results days

QuarterResultsShare move
Quarter to Sep 30, 2026Nov 11, 2026 · Before open+4.6%
Q2 2026Aug 12, 2026 · Before open+2.3%
Q1 2026May 13, 2026 · Before open−7.5%
Q4 2025Feb 11, 2026 · Before open−1.3%
Q3 2025Nov 12, 2025 · Before open−0.3%
Q2 2025Aug 13, 2025 · Before open+2.0%
Q1 2025May 14, 2025 · Before open+7.0%
Q4 2024Feb 12, 2025 · Before open+3.0%
Q3 2024Nov 13, 2024 · Before open−2.9%
Q2 2024Aug 14, 2024 · Before open−2.0%
All 20 quarters
QuarterResultsShare move
Q1 2024May 8, 2024 · Before open−11.3%
Q4 2023Feb 14, 2024 · Before open−8.2%
Q3 2023Nov 8, 2023 · Before open−1.3%
Q2 2023Aug 9, 2023 · After close+2.9%
Q1 2023May 10, 2023 · Before open−2.4%
Q4 2022Feb 8, 2023 · Before open−12.8%
Q3 2022Nov 9, 2022 · Before open−9.6%
Q2 2022Aug 10, 2022 · After close−1.2%
Q1 2022May 11, 2022 · Before open−2.8%
Q4 2021Feb 9, 2022 · Before open+5.2%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (August 2026)Investor deck22 slidesAugust 2026
Surgical Infection Society 45th Annual Meeting (SIS 2026)Conference10 slidesMay 2026
Technical Presentation (June 2025)Technical12 slidesJun 9, 2025
Corporate Update (June 2022)Corporate update42 slidesJune 2022
Investor Presentation (July 2021)Investor deck22 slidesJul 2, 2021
Technical Presentation (December 2020)Technical39 slidesDec 15, 2020
IPO Roadshow (October 2014)IPO roadshow34 slidesOct 31, 2014

Open Decks

Financings

RaiseDate
Warrant exercise of ordinary shares on exercise of existing warrants
Closed: US$26.7M raised · US$3.5 a share · Warrants at US$4.5 for 24 months
Use of proceeds: NDA submission, launch preparations, working capital and general corporate purposes
Aug 13, 2025
Private placement of securities with warrants
Closed: US$14.5M raised · US$3.22 a share · Warrants at US$4 · Citizens JMP
Dealers: Citizens JMP (lead)
Buyers: AIGH (lead investor)
Use of proceeds: Extend cash runway into the third quarter of 2025, beyond expected SHIELD II top-line results
Feb 12, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$16.00 a share on Jun 25, 2020.

Price
US$16.00 a share
Shares offered
3,750,000 ordinary shares
Offering size
US$60 million
Underwriters' option
Up to 562,500 more shares
Listing
PYPD on the Nasdaq Global Market
Underwriters
Barclays, BMO Capital Markets, Raymond James, National Securities Corporation, ODDO BHF, A.G.P. · In the order on the cover

Steps

StepWhen
Draft sent to the SEC in confidenceFeb 24, 2020
Filed publiclyJun 5, 2020
Amended twiceNewest Jun 22, 2020
Shares registered with an exchangeJun 18, 2020
Declared effective by the SECJun 25, 2020
Final prospectus, with the priceJun 29, 2020

Open IPO · From the cover of the final prospectus (424B4) filed Jun 29, 2020

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue0000000000
Cost of revenue1.62M1.82M1.72M1.12M1.01M947.0K411.0K205.0K127.0K
Gross profit-1.62M-1.82M-1.72M-1.12M-1.01M-947.0K-411.0K-205.0K-127.0K
Research and development23.8M22.8M16.1M28.0M30.6M17.0M14.1M12.6M9.74M7.71M
Selling, general and administrative7.18M4.27M5.52M8.01M9.48M7.70M4.48M5.26M4.06M2.55M
Operating income-33.0M-28.0M-22.9M-38.9M-43.1M-26.3M-18.6M-18.4M-13.8M-10.3M
Depreciation and amortization1.46M1.62M1.82M1.72M1.12M1.01M947.0K411.0K205.0K127.0K
EBITDA-31.5M-26.4M-21.0M-37.2M-42.0M-25.3M-17.6M-18.0M-13.6M-10.1M
Interest expense685.0K1.52M1.71M1.02M87.1M17.0K15.0K42.0K16.0K108.0K
Income before tax-34.2M-29.0M-23.8M-39.4M-42.6M36.9M-6.91M5.92M-54.5M-11.4M
Income tax5.00K42.0K69.0K129.0K-1.62M-1.54M-11.7M-24.3M40.7M1.13M
Net income-34.2M-29.0M-23.9M-39.6M-42.6M-36.9M-6.91M5.92M-54.5M-11.4M
Earnings per share, basic2.094.9116.9961.0968.274.4823.69-0.16-92.64-19.37
Earnings per share, diluted2.094.9116.9361.0968.274.4823.690.86

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents6.40M15.6M5.31M8.55M9.82M4.32M3.92M7.77M3.91M10.2M
Short-term investments6.53M004.04M22.4M40.2M22.7M014.0M7.53M
Receivables298.0K118.0K139.0K18.0K24.0K28.0K28.0K
Inventory1.11M0213.0K-118.0K646.0K351.0K-24.0K
Current assets15.2M16.6M6.07M14.2M34.8M47.2M27.4M8.03M18.7M18.3M
Property, plant and equipment5.09M6.08M7.62M9.25M8.76M5.89M6.12M6.19M2.93M847.0K
Total assets22.3M25.2M15.4M26.0M44.2M75.8M33.8M14.5M23.0M19.2M
Accounts payable2.86M2.41M772.0K1.14M4.14M974.0K1.58M1.13M2.02M778.0K
Current liabilities7.74M12.7M7.29M8.55M8.08M2.88M2.58M3.69M3.36M1.70M
Long-term debt634.0K6.38M7.57M47.4M6.62M
Total debt988.0K7.42M10.4M11.6M
Total liabilities11.3M17.5M17.5M20.1M8.28M3.07M2.83M96.2M111.6M53.2M
Shareholders' equity11.0M7.68M-2.10M5.83M36.0M72.8M-87.6M-81.7M-88.6M-34.0M
Shares outstanding18.2M10.2M1.65M669.6K18.8M18.5M562.7K18.8M588.1K588.1K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-27.9M-22.0M-17.2M-34.3M-32.4M-21.6M-17.4M-16.7M-12.3M-9.73M
Capital spending-210.0K-76.0K-196.0K-1.77M-2.65M-781.0K-879.0K-3.07M-1.88M-539.0K
Free cash flow-28.1M-22.0M-17.4M-36.1M-35.0M-22.4M-18.2M-19.8M-14.2M-10.3M
Cash from investing-6.70M-330.0K3.80M16.6M36.9M-40.8M-23.6M11.0M-8.38M-8.07M
Cash from financing25.4M32.4M9.98M16.4M1.03M62.8M37.7M9.39M14.4M26.3M
Share buybacks37.7M9.39M14.4M26.3M
Change in cash-9.21M10.1M-3.46M-1.31M5.55M410.0K-3.27M3.67M-6.31M8.54M

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedNov 13, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerNov 12, 2026Current reportSEC
6-K · Report of a foreign issuerOct 28, 2026Current reportSEC
6-K · Report of a foreign issuerOct 1, 2026Current reportSEC
6-K · Report of a foreign issuerOct 1, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 13, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerAug 12, 2026Current reportSEC
S-8 · Registration statement for employee plansAug 12, 2026Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 12, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerAug 12, 2026Current reportSEC
Show 200 filings
FilingDateTypeFiled with
6-K · Report of a foreign issuerJul 29, 2026Current reportSEC
6-K · Report of a foreign issuerJul 21, 2026Current reportSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
4 · Change in ownershipJul 17, 2026Insider tradeSEC
6-K · Report of a foreign issuerJul 15, 2026Current reportSEC
6-K · Report of a foreign issuerJun 10, 2026Current reportSEC
6-K · Report of a foreign issuerJun 1, 2026Current reportSEC
6-K · Report of a foreign issuerMay 13, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 12, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 4, 2026Big-stake noticeSEC
3 · Initial statement of ownershipApr 6, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 6, 2026Insider tradeSEC
6-K · Report of a foreign issuerMar 31, 2026Current reportSEC
3 · Initial statement of ownershipMar 26, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 26, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 23, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 23, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 23, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
20-F · Annual reportFeb 25, 2026Annual reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 11, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerFeb 11, 2026Current reportSEC
6-K · Report of a foreign issuerFeb 4, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 30, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerDec 31, 2025Current reportSEC
6-K · Report of a foreign issuerDec 16, 2025Current reportSEC
6-K · Report of a foreign issuerDec 3, 2025Current reportSEC
424B5 · ProspectusNov 26, 2025Offer documentSEC
6-K · Report of a foreign issuerNov 26, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 12, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerNov 12, 2025Current reportSEC
6-K · Report of a foreign issuerSep 16, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedSep 8, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerAug 13, 2025Current reportSEC
S-8 · Registration statement for employee plansAug 13, 2025Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 13, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerAug 13, 2025Current reportSEC
6-K · Report of a foreign issuerAug 12, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveAug 7, 2025Other filingsSEC
CORRESP · Letter to the SECAug 4, 2025Other filingsSEC
UPLOAD · Letter from the SECAug 4, 2025Other filingsSEC
SCHEDULE 13G · Big-stake noticeJul 29, 2025Big-stake noticeSEC
F-3 · Registration statementJul 29, 2025Offer documentSEC
6-K · Report of a foreign issuerJul 15, 2025Current reportSEC
6-K · Report of a foreign issuerJun 25, 2025Current reportSEC
DJun 23, 2025Other filingsSEC
6-K · Report of a foreign issuerJun 17, 2025Current reportSEC
6-K · Report of a foreign issuerJun 9, 2025Current reportSEC
6-K · Report of a foreign issuerMay 30, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 28, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerMay 21, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerMay 14, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 3, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerMar 11, 2025Current reportSEC
20-F · Annual reportFeb 26, 2025Annual reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerFeb 12, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 10, 2025Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveJan 31, 2025Other filingsSEC
CORRESP · Letter to the SECJan 28, 2025Other filingsSEC
UPLOAD · Letter from the SECJan 24, 2025Other filingsSEC
F-3 · Registration statementJan 21, 2025Offer documentSEC
6-K · Report of a foreign issuerJan 17, 2025Current reportSEC
DJan 2, 2025Other filingsSEC
6-K · Report of a foreign issuerDec 26, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedDec 12, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerDec 11, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedNov 29, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerNov 29, 2024Current reportSEC
6-K · Report of a foreign issuerNov 13, 2024Current reportSEC
424B5 · ProspectusNov 8, 2024Offer documentSEC
6-K · Report of a foreign issuerNov 8, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedOct 28, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedOct 23, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerOct 1, 2024Current reportSEC
EFFECT · Notice that a registration is effectiveSep 10, 2024Other filingsSEC
CORRESP · Letter to the SECSep 5, 2024Other filingsSEC
UPLOAD · Letter from the SECSep 5, 2024Other filingsSEC
F-3 · Registration statementAug 30, 2024Offer documentSEC
SC 13G/A · Big-stake notice, amendedAug 14, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerAug 14, 2024Current reportSEC
6-K · Report of a foreign issuerAug 14, 2024Current reportSEC
DAug 12, 2024Other filingsSEC
6-K · Report of a foreign issuerAug 2, 2024Current reportSEC
6-K · Report of a foreign issuerJul 19, 2024Current reportSEC
EFFECT · Notice that a registration is effectiveJul 15, 2024Other filingsSEC
CORRESP · Letter to the SECJul 10, 2024Other filingsSEC
UPLOAD · Letter from the SECJul 9, 2024Other filingsSEC
6-K · Report of a foreign issuerJul 2, 2024Current reportSEC
S-8 · Registration statement for employee plansJul 2, 2024Offer documentSEC
F-3 · Registration statementJul 2, 2024Offer documentSEC
6-K · Report of a foreign issuerJun 18, 2024Current reportSEC
6-K · Report of a foreign issuerMay 28, 2024Current reportSEC
6-K · Report of a foreign issuerMay 17, 2024Current reportSEC
6-K · Report of a foreign issuerMay 8, 2024Current reportSEC
6-K · Report of a foreign issuerApr 30, 2024Current reportSEC
SC 13G · Big-stake noticeApr 17, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeApr 5, 2024Big-stake noticeSEC
S-8 · Registration statement for employee plansMar 6, 2024Offer documentSEC
20-F · Annual reportMar 6, 2024Annual reportSEC
SC 13G · Big-stake noticeMar 1, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerFeb 14, 2024Current reportSEC
6-K · Report of a foreign issuerFeb 14, 2024Current reportSEC
EFFECT · Notice that a registration is effectiveFeb 14, 2024Other filingsSEC
CORRESP · Letter to the SECFeb 12, 2024Other filingsSEC
UPLOAD · Letter from the SECFeb 9, 2024Other filingsSEC
F-3 · Registration statementFeb 1, 2024Offer documentSEC
DJan 22, 2024Other filingsSEC
6-K · Report of a foreign issuerJan 5, 2024Current reportSEC
6-K · Report of a foreign issuerNov 8, 2023Current reportSEC
6-K · Report of a foreign issuerNov 7, 2023Current reportSEC
6-K · Report of a foreign issuerOct 11, 2023Current reportSEC
6-K · Report of a foreign issuerOct 10, 2023Current reportSEC
6-K · Report of a foreign issuerOct 10, 2023Current reportSEC
SC 13G · Big-stake noticeSep 20, 2023Big-stake noticeSEC
6-K · Report of a foreign issuerSep 20, 2023Current reportSEC
6-K · Report of a foreign issuerSep 18, 2023Current reportSEC
6-K · Report of a foreign issuerSep 1, 2023Current reportSEC
6-K · Report of a foreign issuerSep 1, 2023Current reportSEC
6-K · Report of a foreign issuerAug 9, 2023Current reportSEC
6-K · Report of a foreign issuerAug 9, 2023Current reportSEC
6-K · Report of a foreign issuerJun 22, 2023Current reportSEC
6-K · Report of a foreign issuerJun 5, 2023Current reportSEC
6-K · Report of a foreign issuerMay 22, 2023Current reportSEC
424B5 · ProspectusMay 19, 2023Offer documentSEC
SC 13G/A · Big-stake notice, amendedMay 17, 2023Big-stake noticeSEC
6-K · Report of a foreign issuerMay 10, 2023Current reportSEC
6-K · Report of a foreign issuerMay 8, 2023Current reportSEC
6-K · Report of a foreign issuerApr 14, 2023Current reportSEC
S-8 · Registration statement for employee plansMar 31, 2023Offer documentSEC
6-K · Report of a foreign issuerMar 31, 2023Current reportSEC
6-K · Report of a foreign issuerMar 31, 2023Current reportSEC
20-F · Annual reportMar 31, 2023Annual reportSEC
424B3 · ProspectusMar 30, 2023Offer documentSEC
424B3 · ProspectusMar 28, 2023Offer documentSEC
6-K · Report of a foreign issuerMar 10, 2023Current reportSEC
F-XMar 2, 2023Other filingsSEC
CBMar 2, 2023Other filingsSEC
6-K · Report of a foreign issuerFeb 21, 2023Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 10, 2023Big-stake noticeSEC
6-K · Report of a foreign issuerFeb 8, 2023Current reportSEC
6-K · Report of a foreign issuerJan 24, 2023Current reportSEC
6-K · Report of a foreign issuerJan 3, 2023Current reportSEC
6-K · Report of a foreign issuerDec 12, 2022Current reportSEC
6-K · Report of a foreign issuerDec 9, 2022Current reportSEC
6-K · Report of a foreign issuerNov 9, 2022Current reportSEC
6-K · Report of a foreign issuerOct 20, 2022Current reportSEC
6-K · Report of a foreign issuerSep 28, 2022Current reportSEC
6-K · Report of a foreign issuerSep 2, 2022Current reportSEC
6-K · Report of a foreign issuerAug 10, 2022Current reportSEC
6-K · Report of a foreign issuerAug 10, 2022Current reportSEC
6-K · Report of a foreign issuerAug 10, 2022Current reportSEC
6-K · Report of a foreign issuerAug 8, 2022Current reportSEC
6-K · Report of a foreign issuerAug 3, 2022Current reportSEC
SC 13G/A · Big-stake notice, amendedJul 15, 2022Big-stake noticeSEC
6-K · Report of a foreign issuerJul 5, 2022Current reportSEC
6-K · Report of a foreign issuerMay 31, 2022Current reportSEC
6-K · Report of a foreign issuerMay 23, 2022Current reportSEC
6-K · Report of a foreign issuerMay 11, 2022Current reportSEC
6-K · Report of a foreign issuerMay 3, 2022Current reportSEC
6-K · Report of a foreign issuerApr 6, 2022Current reportSEC
6-K · Report of a foreign issuerMar 28, 2022Current reportSEC
6-K · Report of a foreign issuerMar 2, 2022Current reportSEC
20-F · Annual reportFeb 28, 2022Annual reportSEC
SC 13G/A · Big-stake notice, amendedFeb 24, 2022Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 24, 2022Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 10, 2022Big-stake noticeSEC
6-K · Report of a foreign issuerFeb 9, 2022Current reportSEC
6-K · Report of a foreign issuerJan 3, 2022Current reportSEC
6-K · Report of a foreign issuerNov 18, 2021Current reportSEC
6-K · Report of a foreign issuerNov 10, 2021Current reportSEC
6-K · Report of a foreign issuerSep 13, 2021Current reportSEC
6-K/A · Report of a foreign issuer, amendedAug 30, 2021Current reportSEC
6-K · Report of a foreign issuerAug 11, 2021Current reportSEC
6-K · Report of a foreign issuerAug 11, 2021Current reportSEC
EFFECT · Notice that a registration is effectiveJul 12, 2021Other filingsSEC
CORRESP · Letter to the SECJul 7, 2021Other filingsSEC

This page holds 200 of 256 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from PolyPid Ltd.’s releases · as of Sep 30, 2026

Common shares
20,311,766
Fully diluted
20,311,766

Fully diluted

LineSharesAs of
Common shares20,311,766Sep 30, 2026

Warrants and options

Lot
Warrants · US$4.50 · expire about Jun 2027
Warrants · US$4.00 · expiry not stated

Share count over time

CountShares
Nov 22, 202620,311,766
Sep 30, 202621,125,704

Open Cap table

Shareholders

HolderSharesValueAs of
Fidelity Nasdaq Composite Index Fund3,013US$14,221May 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Brooke Story
Other companies: LivaNova PLC (Director since 2022 · Since at least Sep 15, 2022); Sigilon Therapeutics Inc (Director · Jun 14, 2021 – May 26, 2022 · Past)
Chairman of the Board · Since at least Dec 16, 2025
Robert Benjamin Stein
Other companies: Protagenic Therapeutics, Inc. (Director · Mar 25, 2024 – Mar 25, 2024 · Past)
Director · Since at least Mar 18, 2026
Dalit Fellous HazanDeputy CEO, EVP, RD, CRA · Since at least Mar 18, 2026
Dikla Czaczkes AkselbradChief Executive Officer · Since at least Mar 18, 2026
Itzhak KrinskyDirector · Since at least Mar 18, 2026
Jonathan MissulawinChief Financial Officer · Since at least Mar 18, 2026
Joseph BenAmramDirector · Since at least Mar 18, 2026
Nir Dror-DarwishDirector · Since at least Mar 18, 2026
Nurit Tweezer-ZaksChief Medical Officer · Aug 12, 2025 – Nov 5, 2026 · Past
Ori WarshavskyPolyPid Investor Relations and Media Contacts · Since at least Mar 18, 2026
All 12 people
PersonSeat
Yechezkel BarenholzDirector · Since at least Mar 18, 2026
Yitzchak Shlomo JacobovitzDirector · Since at least Mar 18, 2026

Open People

Log in to ask 6ix AI your own questions about PolyPid Ltd.